{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:44:43Z","timestamp":1763415883056,"version":"3.45.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Africa Regional International Staff\/Student Exchange (ARISE) II: Food Security and Sustainable Human Wellbeing scholarship"},{"name":"University of Ghana College of Health Sciences Postgraduate endowment scholarship award"},{"name":"University of Cape Town Faculty of Health Sciences Postgraduate Research Training grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02787-0","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:52:59Z","timestamp":1763412779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysbetalipoproteinaemia in genetically predisposed Ghanaians"],"prefix":"10.1186","volume":"24","author":[{"given":"Richmond Owusu","family":"Ateko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian David","family":"Marais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk Jacobus","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Mawuli","family":"Adadey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas Ekow","family":"Thomford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane Mary","family":"Blackhurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"1","key":"2787_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1210\/clinem\/dgac503","volume":"108","author":"M Paquette","year":"2022","unstructured":"Paquette M, Bernard S, Baass A. Dysbetalipoproteinemia is associated with increased risk of coronary and peripheral vascular disease. J Clin Endocrinol Metab. 2022;108(1):184\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2787_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.5114\/aoms.2019.86972","volume":"16","author":"VA Pallazola","year":"2020","unstructured":"Pallazola VA, Sathiyakumar V, Park J, Vakil RM, Toth P, Lazo-Elizondo M, et al. Modern prevalence of dysbetalipoproteinemia (Fredrickson-levy-lees type III hyperlipoproteinemia). Arch Med Sci. 2020;16(5):993\u20131003.","journal-title":"Arch Med Sci"},{"issue":"11","key":"2787_CR3","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Huang Y, Rall SC. Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res. 1999;40(11):1933\u201349.","journal-title":"J Lipid Res"},{"key":"2787_CR4","doi-asserted-by":"publisher","DOI":"10.21037\/jlpm.2019.04.04","volume":"4","author":"C Koopal","year":"2019","unstructured":"Koopal C, Visseren FLJ. Non-HDL-C\/TC ratio: a useful screenings test for dysbetalipoproteinemia. J Lab Precis Med. 2019;4:18.","journal-title":"J Lab Precis Med"},{"issue":"2","key":"2787_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MED.0000000000000316","volume":"24","author":"C Koopal","year":"2017","unstructured":"Koopal C, Marais AD, Visseren FL. Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder. Curr Opin Endocrinol Diabetes Obes. 2017;24(2):133\u20139.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2787_CR6","doi-asserted-by":"crossref","unstructured":"Hazzard WR. Dysbetalipoproteinemia and Type III Hyperlipidemia. In: Encyclopedia of Endocrine Diseases. Elsevier; 2004;687-91.","DOI":"10.1016\/B0-12-475570-4\/00404-2"},{"key":"2787_CR7","first-page":"1953","volume-title":"The metabolic and molecular basis of inherited disease","author":"RW Mahley","year":"1995","unstructured":"Mahley RW, Rall SC. Type III hyperlipoproteinaemia (dysbetalipoproteinaemia): the role of Apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. 7th ed. New York: McGraw-Hill; 1995. pp. 1953\u201380.","edition":"7"},{"issue":"16","key":"2787_CR8","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.1016\/S0021-9258(18)99249-5","volume":"266","author":"P Lohse","year":"1991","unstructured":"Lohse P, Mann WA, Stein EA, Brewer HB. Jr. Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the Apolipoprotein E gene combined with severe type III hyperlipoproteinemia. J Biol Chem. 1991;266(16):10479\u201384.","journal-title":"J Biol Chem"},{"issue":"19","key":"2787_CR9","doi-asserted-by":"publisher","first-page":"13642","DOI":"10.1016\/S0021-9258(18)42261-2","volume":"267","author":"P Lohse","year":"1992","unstructured":"Lohse P, Rader DJ, Brewer HB. Heterozygosity for apolipoprotein-E-4(Philadelphia)(Glu(13)-]Lys, Arg(145)-]Cys) is associated with incomplete dominance of type-III hyperlipoproteinemia. J Biol Chem. 1992;267(19):13642\u20136.","journal-title":"J Biol Chem"},{"issue":"1","key":"2787_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface Heparan sulfate proteoglycans and Apolipoprotein E. J Lipid Res. 1999;40(1):1\u201316.","journal-title":"J Lipid Res"},{"issue":"3","key":"2787_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MOL.0b013e328338cabc","volume":"21","author":"KJ Williams","year":"2010","unstructured":"Williams KJ, Chen K. Recent insights into factors affecting remnant lipoprotein uptake. Curr Opin Lipidol. 2010;21(3):218\u201328.","journal-title":"Curr Opin Lipidol"},{"issue":"18","key":"2787_CR12","doi-asserted-by":"publisher","first-page":"13421","DOI":"10.1016\/S0021-9258(17)36849-7","volume":"269","author":"ZS Ji","year":"1994","unstructured":"Ji ZS, Fazio S, Mahley RW. Variable heparan sulfate proteoglycan binding of Apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J Biol Chem. 1994;269(18):13421\u20138.","journal-title":"J Biol Chem"},{"issue":"6","key":"2787_CR13","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/hep.23916","volume":"52","author":"K Chen","year":"2010","unstructured":"Chen K, Liu ML, Schaffer L, Li M, Boden G, Wu X, et al. Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins. Hepatology. 2010;52(6):1957\u201367.","journal-title":"Hepatology"},{"issue":"4","key":"2787_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MOL.0000000000000192","volume":"26","author":"D Marais","year":"2015","unstructured":"Marais D. Dysbetalipoproteinemia: an extreme disorder of remnant metabolism. Curr Opin Lipidol. 2015;26(4):292\u20137.","journal-title":"Curr Opin Lipidol"},{"issue":"11","key":"2787_CR15","first-page":"892","volume":"92","author":"DJ Blom","year":"2002","unstructured":"Blom DJ, Byrnes P, Jones S, Marais AD. Dysbetalipoproteinaemia\u2013clinical and pathophysiological features. S Afr Med J. 2002;92(11):892\u20137.","journal-title":"S Afr Med J"},{"issue":"1","key":"2787_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/10408363.2013.870526","volume":"51","author":"AD Marais","year":"2014","unstructured":"Marais AD, Solomon GA, Blom DJ. Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E. Crit Rev Clin Lab Sci. 2014;51(1):46\u201362.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"5","key":"2787_CR17","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1373\/clinchem.2004.047001","volume":"51","author":"DJ Blom","year":"2005","unstructured":"Blom DJ, O\u2019Neill FH, Marais AD. Screening for dysbetalipoproteinemia by plasma cholesterol and Apolipoprotein B concentrations. Clin Chem. 2005;51(5):904\u20137.","journal-title":"Clin Chem"},{"issue":"4","key":"2787_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jacl.2007.07.006","volume":"1","author":"A Sniderman","year":"2007","unstructured":"Sniderman A, Tremblay A, Bergeron J, Gagne C, Couture P. Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B. J Clin Lipidol. 2007;1(4):256\u201363.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"2787_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/clinchem\/hvac213","volume":"69","author":"AM Bea","year":"2023","unstructured":"Bea AM, Cenarro A, Marco-Bened V, Laclaustra M, Martn C, Ibarretxe D, et al. Diagnosis of familial dysbetalipoproteinemia based on the lipid abnormalities driven by APOE2\/E2 genotype. Clin Chem. 2023;69(2):140\u20138.","journal-title":"Clin Chem"},{"issue":"1","key":"2787_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1194\/jlr.D200013-JLR200","volume":"44","author":"DJ Blom","year":"2003","unstructured":"Blom DJ, Byrnes P, Jones S, Marais AD. Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia. J Lipid Res. 2003;44(1):212\u20137.","journal-title":"J Lipid Res"},{"issue":"5","key":"2787_CR21","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.0092-5853.2003.00520.x","volume":"85","author":"T Reardon","year":"2003","unstructured":"Reardon T, Timmer CP, Barrett CB, Berdegu\u00e9 J. The rise of supermarkets in Africa, Asia, and Latin America. Am J Agric Econ. 2003;85(5):1140\u20136.","journal-title":"Am J Agric Econ"},{"issue":"3","key":"2787_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pcad.2013.09.016","volume":"56","author":"A Schram","year":"2013","unstructured":"Schram A, Labont\u00e9 R, Sanders D. Urbanization and international trade and investment policies as determinants of non-communicable diseases in sub-Saharan Africa. Prog Cardiovasc Dis. 2013;56(3):281\u2013301.","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"2787_CR23","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1017\/S0029665114001669","volume":"74","author":"WK Bosu","year":"2015","unstructured":"Bosu WK. An overview of the nutrition transition in West africa: implications for non-communicable diseases. Proc Nutr Soc. 2015;74(4):466\u201377.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"2787_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-024-01027-x","volume":"20","author":"E Nyarko","year":"2024","unstructured":"Nyarko E, Bartelme\u00df T. Drivers of consumer food choices of multinational corporations\u2019 products over local foods in Ghana: a maximum difference scaling study. Glob Health. 2024;20(1):22.","journal-title":"Glob Health"},{"key":"2787_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3901-4","volume":"16","author":"R Ofori-Asenso","year":"2016","unstructured":"Ofori-Asenso R, Agyeman AA, Laar A, Boateng D. Overweight and obesity epidemic in Ghana\u2014a systematic review and meta-analysis. BMC Public Health. 2016;16:1\u20138.","journal-title":"BMC Public Health"},{"issue":"1","key":"2787_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1017\/S000711451400052X","volume":"112","author":"LK Frank","year":"2014","unstructured":"Frank LK, Kr\u00f6ger J, Schulze MB, Bedu-Addo G, Mockenhaupt FP, Danquah I. Dietary patterns in urban Ghana and risk of type 2 diabetes. Br J Nutr. 2014;112(1):89\u201398.","journal-title":"Br J Nutr"},{"issue":"3","key":"2787_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","volume":"31","author":"JE Hixson","year":"1990","unstructured":"Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545\u20138.","journal-title":"J Lipid Res"},{"issue":"2","key":"2787_CR28","first-page":"187","volume":"43","author":"SH Hsia","year":"1995","unstructured":"Hsia SH, Connelly PW, Hegele RA. Restriction isotyping of Apolipoprotein E R145C in type III hyperlipoproteinemia. J Investig Med. 1995;43(2):187\u201394.","journal-title":"J Investig Med"},{"issue":"Suppl","key":"2787_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/14034950701355635","volume":"69","author":"ML Masemola","year":"2007","unstructured":"Masemola ML, Alberts M, Urdal P. Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population. Scand J Public Health. 2007;69(Suppl):60\u20135.","journal-title":"Scand J Public Health"},{"key":"2787_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-194","volume":"7","author":"M Atadzhanov","year":"2014","unstructured":"Atadzhanov M, Mwaba MH, Mukomena PN, Lakhi S, Mwaba P, Rayaprolu S, et al. Frequency of APOE, MTHFR and ACE polymorphisms in the Zambian population. BMC Res Notes. 2014;7:194.","journal-title":"BMC Res Notes"},{"issue":"3","key":"2787_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4314\/ahs.v16i3.28","volume":"16","author":"DM Tanyanyiwa","year":"2016","unstructured":"Tanyanyiwa DM, Marais AD, Byrnes P, Jones S. The influence of ApoE genotype on the lipid profile and lipoproteins during normal pregnancy in a Southern African population. Afr Health Sci. 2016;16(3):853\u20139.","journal-title":"Afr Health Sci"},{"key":"2787_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.689756","volume":"12","author":"CC Soo","year":"2021","unstructured":"Soo CC, Farrell MT, Tollman S, Berkman L, Nebel A, Ramsay M. Apolipoprotein E genetic variation and its association with cognitive function in rural-dwelling older South Africans. Front Genet. 2021;12:689756.","journal-title":"Front Genet"},{"issue":"5","key":"2787_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284697","volume":"18","author":"NE Thomford","year":"2023","unstructured":"Thomford NE, Anyanful A, Ateko RO, Blackhurst D, Biney RP, Boadi D, et al. Apolipoprotein E genetic variation, atherogenic index and cardiovascular disease risk assessment in an African population: an analysis of HIV and malaria patients in Ghana. PLoS ONE. 2023;18(5):e0284697.","journal-title":"PLoS ONE"},{"issue":"6","key":"2787_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"issue":"6","key":"2787_CR35","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1172\/JCI113243","volume":"80","author":"MS Weintraub","year":"1987","unstructured":"Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in Apolipoprotein E. J Clin Invest. 1987;80(6):1571\u20137.","journal-title":"J Clin Invest"},{"issue":"9","key":"2787_CR36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.5551\/jat.RV17023","volume":"25","author":"T Hirano","year":"2018","unstructured":"Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb. 2018;25(9):771\u201382.","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"2787_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/01.ATV.17.5.865","volume":"17","author":"WJ de Villiers","year":"1997","unstructured":"de Villiers WJ, van der Westhuyzen DR, Coetzee GA, Henderson HE, Marais AD. The Apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance. Arterioscler Thromb Vasc Biol. 1997;17(5):865\u201372.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02787-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02787-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02787-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:53:01Z","timestamp":1763412781000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02787-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2787"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02787-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the University of Cape Town Faculty of Health Sciences Human Research Ethics Committee (Ref: HREC 773\/2019) and the Korle-Bu Teaching Hospital Institutional Review Board (Ref: KBTH-IRB\/000146\/2019). All participants provided written informed consent before their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"367"}}